Evaluation of three individual glucosyltransferases produced by Streptococcus mutans using monoclonal antibodies. 1996

Y Tomita, and X Zhu, and K Ochiai, and Y Namiki, and T Okada, and T Ikemi, and K Fukushima
Department of Microbiology, Nihon University School of Dentistry at Matsudo, Chiba, Japan.

We previously established murine hybridomas producing a monoclonal antibody monospecific against three glucosyltransferases (I, SI and S) of Streptococcus mutans which contribute to dental caries formation. Here, we developed a new immunochemical technique (cross-dot system) with which individual levels of glucosyltransferases expressed by S. mutans can be evaluated. We also examined glucosyltransferase production and in vitro artificial plaque formation by a reference strain and several clinical isolates of S. mutans. The findings indicate that the levels of glucosyltransferases produced greatly vary with the cells and the culture medium, and that the cells producing high levels of both glucosyltransferase-SI and glucosyltransferase-I enzymes may possess high in vitro artificial plaque forming ability. We suggest that the cross-dot system will be useful for estimating the cariogenic potential of S. mutans isolates.

UI MeSH Term Description Entries
D003773 Dental Plaque A film that attaches to teeth, often causing DENTAL CARIES and GINGIVITIS. It is composed of MUCINS, secreted from salivary glands, and microorganisms. Plaque, Dental
D005964 Glucosyltransferases Enzymes that catalyze the transfer of glucose from a nucleoside diphosphate glucose to an acceptor molecule which is frequently another carbohydrate. EC 2.4.1.-. Glucosyltransferase
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D013295 Streptococcus mutans A polysaccharide-producing species of STREPTOCOCCUS isolated from human dental plaque.
D015151 Immunoblotting Immunologic method used for detecting or quantifying immunoreactive substances. The substance is identified by first immobilizing it by blotting onto a membrane and then tagging it with labeled antibodies. Dot Immunoblotting,Electroimmunoblotting,Immunoelectroblotting,Reverse Immunoblotting,Immunoblotting, Dot,Immunoblotting, Reverse,Dot Immunoblottings,Electroimmunoblottings,Immunoblottings,Immunoblottings, Dot,Immunoblottings, Reverse,Immunoelectroblottings,Reverse Immunoblottings

Related Publications

Y Tomita, and X Zhu, and K Ochiai, and Y Namiki, and T Okada, and T Ikemi, and K Fukushima
January 1993, Infection and immunity,
Y Tomita, and X Zhu, and K Ochiai, and Y Namiki, and T Okada, and T Ikemi, and K Fukushima
January 1978, Advances in experimental medicine and biology,
Y Tomita, and X Zhu, and K Ochiai, and Y Namiki, and T Okada, and T Ikemi, and K Fukushima
July 2002, Clinical and diagnostic laboratory immunology,
Y Tomita, and X Zhu, and K Ochiai, and Y Namiki, and T Okada, and T Ikemi, and K Fukushima
June 2010, Journal of bacteriology,
Y Tomita, and X Zhu, and K Ochiai, and Y Namiki, and T Okada, and T Ikemi, and K Fukushima
June 1983, FEBS letters,
Y Tomita, and X Zhu, and K Ochiai, and Y Namiki, and T Okada, and T Ikemi, and K Fukushima
September 2005, Bioscience, biotechnology, and biochemistry,
Y Tomita, and X Zhu, and K Ochiai, and Y Namiki, and T Okada, and T Ikemi, and K Fukushima
February 1983, Infection and immunity,
Y Tomita, and X Zhu, and K Ochiai, and Y Namiki, and T Okada, and T Ikemi, and K Fukushima
August 1987, Infection and immunity,
Y Tomita, and X Zhu, and K Ochiai, and Y Namiki, and T Okada, and T Ikemi, and K Fukushima
September 1991, Carbohydrate research,
Y Tomita, and X Zhu, and K Ochiai, and Y Namiki, and T Okada, and T Ikemi, and K Fukushima
September 1992, Journal of bacteriology,
Copied contents to your clipboard!